Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent

[1]  C. Contag,et al.  Early Cancer Detection at the Epithelial Surface , 2015, Cancer journal.

[2]  E. Yang,et al.  PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers , 2015, Breast Cancer Research and Treatment.

[3]  I. Ellis,et al.  DNA damage response markers are differentially expressed in BRCA-mutated breast cancers , 2015, Breast Cancer Research and Treatment.

[4]  I. Ellis,et al.  Biological and clinical significance of PARP1 protein expression in breast cancer , 2014, Breast Cancer Research and Treatment.

[5]  B. Tudek,et al.  PARP-1 Expression is Increased in Colon Adenoma and Carcinoma and Correlates with OGG1 , 2014, PloS one.

[6]  T. Reiner,et al.  PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging , 2014, Neoplasia.

[7]  Greg M. Thurber,et al.  Effect of Small-Molecule Modification on Single-Cell Pharmacokinetics of PARP Inhibitors , 2014, Molecular Cancer Therapeutics.

[8]  S. Tsao,et al.  PARP1 Is Overexpressed in Nasopharyngeal Carcinoma and Its Inhibition Enhances Radiotherapy , 2013, Molecular Cancer Therapeutics.

[9]  P. Bosco,et al.  Poly (ADP-ribose) Polymerase 1 Protein Expression in Normal and Neoplastic Prostatic Tissue , 2013, European journal of histochemistry : EJH.

[10]  Greg M. Thurber,et al.  Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo , 2013, Nature Communications.

[11]  K. Safranow,et al.  Colorectal cancers differ in respect of PARP-1 protein expression. , 2012, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[12]  Rajakishore Mishra.  Biomarkers of oral premalignant epithelial lesions for clinical application. , 2012, Oral oncology.

[13]  Jonathan T. C. Liu,et al.  Multi-color miniature dual-axis confocal microscope for point-of-care pathology. , 2012, Optics letters.

[14]  S. Serrano,et al.  Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  R. Weissleder,et al.  Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents. , 2012, Neoplasia.

[16]  P. Bosco,et al.  PARP-1 protein expression in glioblastoma multiforme , 2012, European journal of histochemistry : EJH.

[17]  E M Sevick-Muraca,et al.  Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. , 2012, Annual review of medicine.

[18]  H. Sterenborg,et al.  Image‐guided surgery in head and neck cancer: Current practice and future directions of optical imaging , 2012, Head & neck.

[19]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[20]  Merlijn Hutteman,et al.  The clinical use of indocyanine green as a near‐infrared fluorescent contrast agent for image‐guided oncologic surgery , 2011, Journal of surgical oncology.

[21]  Sunkuk Kwon,et al.  Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide. , 2011, Bioorganic & medicinal chemistry.

[22]  L. Ellisen.  PARP inhibitors in cancer therapy: promise, progress, and puzzles. , 2011, Cancer cell.

[23]  Eric P Kaldjian,et al.  Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types. , 2010, Genes & cancer.

[24]  Ralf Kiesslich,et al.  Advances in endoscopic imaging of colorectal neoplasia. , 2010, Gastroenterology.

[25]  S. Kaufmann,et al.  PARP inhibition: PARP1 and beyond , 2010, Nature Reviews Cancer.

[26]  Thomas D. Wang,et al.  Molecular imaging in gastrointestinal endoscopy. , 2010, Gastroenterology.

[27]  Nathan O. Loewke,et al.  Micromirror-scanned dual-axis confocal microscope utilizing a gradient-index relay lens for image guidance during brain surgery. , 2010, Journal of biomedical optics.

[28]  C. Scully,et al.  Oral cancer: current and future diagnostic techniques. , 2008, American journal of dentistry.

[29]  Thomas D. Wang,et al.  Efficient rejection of scattered light enables deep optical sectioning in turbid media with low-numerical-aperture optics in a dual-axis confocal architecture. , 2008, Journal of biomedical optics.

[30]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[31]  Christopher H Contag,et al.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. , 2008, Nature medicine.

[32]  Kathryn E. Luker,et al.  Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.

[33]  Hiroyuki Yamamoto,et al.  Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. , 2006, European journal of cancer.

[34]  V. Ntziachristos.  Fluorescence molecular imaging. , 2006, Annual review of biomedical engineering.

[35]  G. Argenziano,et al.  Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. , 2005, Human pathology.

[36]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[37]  G. Poirier,et al.  PARP-1, a determinant of cell survival in response to DNA damage. , 2003, Experimental hematology.

[38]  T. Day,et al.  Oral Cancer and Precancerous Lesions , 2002, CA: a cancer journal for clinicians.

[39]  R. Weissleder.  A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[40]  S. Lippman,et al.  Predicting cancer development in oral leukoplakia: ten years of translational research. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  A. Bowman,et al.  Applied smoothing techniques for data analysis : the kernel approach with S-plus illustrations , 1999 .

[42]  I. Bièche,et al.  Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  T. Calcaterra,et al.  Laryngeal dysplasia. A clinicopathologic study , 1995, Cancer.

[44]  P. J. Green,et al.  Density Estimation for Statistics and Data Analysis , 1987 .

[45]  B. Barlogie.  Abnormal cellular DNA content as a marker of neoplasia. , 1984, European journal of cancer & clinical oncology.

[46]  S. Bahn,et al.  In vivo staining properties of oral cancer. , 1965, American journal of surgery.

[47]  I. Ellis,et al.  Biological and clinical significance of PARP 1 protein expression in breast cancer , 2016 .

[48]  Ralph Weissleder,et al.  Intravital Imaging , 2011, Cell.

[49]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .